Boston Scientific has struggled to bring a TAVR platform to the U.S. market to compete with Edwards and Medtronic. It faced a setback in 2020 when Acurate Neo did not achieve noninferiority in a ...

Boston Scientific, Inc. BSX has obtained a CE Mark for the ACURATE Prime Aortic Valve System ... in challenging or larger ...

William Plovanic has given his Buy rating due to a combination of factors including Boston Scientific’s resilience in addressing the challenges faced by its ACURATE ... of -2.1% and a 41.83% ...